-
PDF
- Split View
-
Views
-
Cite
Cite
Daniel W Mutithu, Riyaadh Roberts, Rodgers Manganyi, Ntobeko A B Ntusi, Chronic rheumatic heart disease with recrudescence of acute rheumatic fever on histology: a case report, European Heart Journal - Case Reports, Volume 6, Issue 7, July 2022, ytac278, https://doi.org/10.1093/ehjcr/ytac278
- Share Icon Share
Abstract
Rheumatic heart disease (RHD) is endemic in sub-Saharan Africa where it is the leading cause of cardiovascular mortality in the young. Rheumatic heart disease results from recurrent episodes of acute rheumatic fever (ARF), which are often difficult to diagnose clinically. Acute rheumatic fever may be diagnosed based on the revised Jones Criteria 2015 for the diagnosis of ARF. Histologically, acute rheumatic valvulitis manifests with active inflammation characterized by lymphocytic infiltration, Aschoff bodies, and Anitschkow cells. Chronic rheumatic valvulitis is associated with neovascularization, and/or dystrophic calcification. The combination of histological features of both ARF and chronic RHD is a rare finding.
Here we report on a case of a 59-year-old woman with mixed aortic and mitral valve disease of probable rheumatic aetiology (elevated C-reactive protein and prolonged PR interval) and with histological evidence of lymphocytic infiltration, Aschoff bodies, and fibrinoid necrosis admixed with features of chronic RHD.
Cases of chronic RHD admixed with ARF are very rare; however, they should be considered in regions with a high prevalence of RHDs.
In high-risk areas, consideration of acute rheumatic fever (ARF) in the differential diagnosis should not be ruled out despite not meeting the criteria for definite ARF diagnosis as per revised Jones Criteria 2015.
Infective endocarditis or ARF should be considered in the differential diagnosis of patients presenting with rapidly declining ventricular function in rheumatic heart disease endemic areas in all regions of the world.
Introduction
Rheumatic heart disease (RHD) is endemic in low- and middle-income countries (LMICs).1 Rheumatic heart disease follows repeated acute rheumatic fever (ARF) episodes resulting in valvular stenosis, regurgitation, heart failure, left ventricular (LV) dysfunction, arrhythmias, and pulmonary hypertension.2 Incidents of ARF are mostly prevalent among children aged 5–14 years and uncommon in persons 45 years and older.2,3 Rheumatic heart disease is an important cause of infective endocarditis in LMICs, including sub-Saharan Africa (SSA). Rheumatic heart disease is diagnosed clinically and confirmed echocardiographically or using other imaging modalities; ARF is diagnosed based on the revised Jones Criteria.4
Pathologically, chronic RHD shows features of chronicity such as stromal neovascularization, fibrosis, calcification, and/or chronic inflammation. It is rare for histological features of ARF to coincide with those of RHD.5 Here we report on a patient diagnosed with RHD who underwent elective aortic and mitral valve (MV) replacement and was confirmed histologically to have RHD as well as coincident ARF, with evidence of acute valvulitis.
Timeline
June–August 2019 |
|
15 October 2019 |
|
22 October 2019 |
|
18 November 2019 |
|
June–August 2019 |
|
15 October 2019 |
|
22 October 2019 |
|
18 November 2019 |
|
June–August 2019 |
|
15 October 2019 |
|
22 October 2019 |
|
18 November 2019 |
|
June–August 2019 |
|
15 October 2019 |
|
22 October 2019 |
|
18 November 2019 |
|
Case report
A 59-year-old woman of sober habits with a 10-year history of poorly controlled Type 2 diabetes, hypertension, and no history of ARF, prior myocarditis, or other known structural heart disease presented with acutely decompensated heart failure. She reported in the past 2 months symptoms of breathlessness, shortness of breath, declining effort tolerance, orthopnoea, bipedal oedema, and paroxysmal nocturnal dyspnoea. Her performance status declined from a NYHA functional Classes II–IV within 3 months.
Physical examination revealed no fever, no arthritis, no chorea, no erythema magnatum nor subcutaneous nodules. Further examination showed a normal blood pressure of 140/60 mmHg with a wide pulse pressure, a heart rate of 98 bpm, a collapsing pulse, displaced apical impulse, and elevated jugular venous pressure. Cardiac auscultation showed a normal soft S1, a normal S2, and an S3 gallop. A 3/6 pansystolic murmur in the mitral area, loudest on expiration, was heard, in keeping with MR. She also had a 2/4 early diastolic murmur with arterial findings of severe AR and a widened pulse pressure. The 12-lead ECG showed abnormal QRS wave pattern, repolarization changes, and 1st degree atrioventricular (A-V) block (PR 330 ms) (Figure 1). On chest radiography, there was cardiomegaly, bilateral pleural effusions, upper lobe pulmonary venous diversion in keeping with heart failure, and prominent pulmonary arteries (Figure 2A and B). Transthoracic echocardiography (TTE) with two-dimensional (2D) Doppler imaging showed mildly dilated LV size and normal LV function (LV dimension in diastole (d) 54 mm, and LVEF 60%). The echocardiographic assessment of the right ventricle (RV) and the pulmonary valve showed pulmonary hypertension with normal sized RV with normal RV function and normal pulmonary valve with mild tricuspid regurgitation (TR − TR Vmax 3.66 m/s, TR Pmax 54 mmHg, right atrial (RA) pressure 20 mmHg, RV systolic pressure 74 mmHg, RA area 19.7 cm2). Further, left atrial assessment showed a mildly dilated left atrium (43 mm). Preoperative TTE showed a tri-leaflet AV with calcified lesions on the non-coronary cusps (NCC), and severe AR. Transthoracic echocardiography of MV showed thickened leaflet tips with severe MR (Figure 3A–H and Supplementary material). Coronary angiography showed unobstructed epicardial coronary vessels and confirmed severe AR and MR. Laboratory examination showed elevated CRP 9 mg/dL, and normal white blood cells 7.62 × 109/L. Anti-DNAse B and anti-steptolysin O-titres were not performed. Blood cultures were performed but the bacterial growth had not occurred by the time the patient underwent valve replacement surgery. Microbiology tests for gram-negative bacteria were negative and polymerase chain reaction testing for common bacteria was also negative.

The 12-lead electrocardiogram with abnormal QRS wave pattern (QRS 82 ms), repolarization changes, and 1st degree a–v block (PR 330 ms).

(A and B) chest X-ray transverse view showing cardiomegaly and upper lobe pulmonary venous diversion (A) and bilateral pleural effusions (B).

(A–H) Preoperative 2D Doppler TTE showing mildly dilated left ventricular, and normal right ventricular and right atrial. (A) Normal pulmonary valve with mild TR. (B) Calcified tri-leaflet aortic valve (C) with severe AR (D and E), thickened mitral valve (F and G) with severe MR (H).
The patient was diagnosed with valvular heart disease of probable rheumatic aetiology and with severe AR and MR complicated by heart failure. She was started on heart failure pharmacotherapy and referred for double valve replacement surgery. On-table, transoesophageal echocardiography was performed and showed a large vegetation on the anterior MV leaflet, and another on the NCC of the AV. In addition, Grade III diastolic dysfunction was noted, a large pleural effusion on the right was also seen. She underwent open-heart surgery and had AV and MV replacement, both with bioprosthetic tissue valves, based on patient’s preference. During the operation, it was evident that below the AV there was small root abscess and vegetation on the AV and MV, confirming chronic infective endocarditis. The patient was treated for culture-negative infective endocarditis. The patient was started on an antibiotic therapy (penicillin G 5 million Unit IV 6 hourly for 4 weeks, gentamycin 80 mg IV three times a day for 2 weeks, doxycycline 100 milligrams orally twice a day for 4 weeks), discharged home well, and has been doing well on follow-up visits. Her post-surgical course was uneventful.
The histopathological assessment showed features of concomitant ARF in a background of chronic RHD. The MV showed evidence of a chronic RHD, with moderate-to-severe fibrosis of the valves, scattered stromal histiocytes, and foci of neovascularization with characteristic thick-walled vessels (Figure 4A and B). The AV showed chronic RHD with stromal neovascularization, fibrosis, and chronic inflammation. Additionally, discrete foci of acute rheumatic valvulitis were evident, with Aschoff bodies containing Anitschkow cells and central fibrinoid necrosis (Figure 5A–D).

(A and B). Haematoxylin and eosin staining of mitral valves. (A) Severe fibrosis (solid arrows) (magnification 40×), (B) scattered stromal histiocytes (solid arrows) and foci of neovascularization with thick-walled vessels (dotted arrows) (magnification 200×).

(A–D) Haematoxylin and eosin staining of aortic valve. (A) Hyalinization (solid arrows) and Aschoff bodies (dotted arrow) (magnification 100×), (B) fibrinoid necrosis (magnification 400×), (C) Aschoff body (magnification 200×). (D) Aschoff body with characteristic Anitschkow cells (magnification 400×).
Discussion
Rheumatic heart disease is endemic in LMICs, including SSA.1,6 Prevalence of RHD in SSA was 864/100 000 in 2017.7 The reported incidence of ARF is declining, and likely reflects underdiagnosis and improving public health.8
In RHD, MV lesions (stenosis and/or regurgitation) are found in 5060%, while mixed MV and AV disease (as in our patient) occurs in ∼20% of RHD patients.9 As per the revised Jones Criteria 2015 for diagnosis of ARF, a combination of two major criteria or one major plus two minor criteria is required to diagnose a definitive ARF.4 In this case, however, the patient presented with two minor criteria and had no history of ARF, therefore, at best was diagnosed with probable ARF.
We report on a case of chronic RHD with acute recrudescence of ARF confirmed histologically, with infective endocarditis, severe AR, and severe MR, and complicated by heart failure. The fact that ARF is rare in individuals older than 45 years makes it unique that here we report a 59-year-old individual with histologically confirmed ARF.
In this case, preoperative TTE could not rule out or confirm ARF and preoperative TEE was not suggested since there was no doubt on the diagnosis of RHD. On-table TEE provided a better assessment of the MV by showing the presence of vegetations on the MV and confirmed intraoperatively. Preoperative TEE would have provided more findings than did TTE towards the workup of the patient by indicating the presence of infective endocarditis. Transthoracic echocardiography has a better sensitivity and provides a clearer assessment of valve morphology which would otherwise have been impeded in TTE due to acoustic shadowing.10–12 This underscores the importance of the role of preoperative TEE in the diagnosis of valvular heart disease especially in RHD endemic regions.
Histologically RHD is characterized by neovascularization and lymphocytic cell infiltration. On the other hand, ARF is characterized histologically by fibrinoid necrosis, Aschoff bodies, and Anitschkow cells. In this case, histological findings confirmed chronic RHD in both aortic and MVs. In addition, the AV showed Aschoff bodies, fibrinoid necrosis, neovascularization, moderate to severe stromal fibrosis, and macrophages compatible with acute rheumatic valvulitis on a background of chronic rheumatic valvulopathy. While Aschoff bodies in acute valvulitis and carditis have been reported elsewhere,13,14 admixed of acute on chronic rheumatic valvulitis is exceptionally rare. Therefore, our report intends to create awareness of existing ARF cases that may go unnoticed especially in endemic areas.
Conclusion
Cases of chronic RHD admixed with ARF are very rare, however, they should be considered in regions with a high prevalence of RHD.
Lead author biography
Daniel W. Mutithu is currently a PhD fellow at the Department of Medicine, University of Cape Town, South Africa. Daniel does research on understanding the pathogenesis of valvular heart diseases using histopathology and metabolomics (LC-mass spectrometry and MALDI imaging). He is interested in multi-omics biomarker research. Daniel has a MSc Medical Biotechnology from Wageningen University & Research, Netherlands, and a BSc (Hons) Biotechnology from Kenyatta University, Kenya. Further, he is a CoD member and convener for early careers sub-committee of Metabolomics Association of South Africa. He is also involved in tutoring and facilitating MBChB small-groups learning at the Faculty of Health Sciences, University of Cape Town.
Supplementary material
Supplementary material is available at European Heart Journal – Case Reports online.
Acknowledgements
Authors acknowledge Prof. Dhiren Govender and A/Prof. Richard Naidoo for technical advice and providing facilities for histology experiments; Olukayode Aremu, Evelyn Lumngwena, and Padmini Govender for help with sample collection and preparation of H&E slides; A/Prof. Sebastian Skatulla for availing funds for the project.
Slide sets: A fully edited slide set detailing these cases and suitable for local presentation is available online as Supplementary data.
Consent: The authors confirm that written consent for submission and publication of this case report including images and associated text has been obtained from the patient in line with COPE guidance. The study was approved by UCT’s Faculty of Health Human Research Ethics Committee (HREC REF:574/2018).
Conflict of interest: None declared.
Funding: This research was not funded.
Comments